Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
NCT00233558 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2007-04-24
Summary
The purpose of the study is to evaluate the clinical efficacy of scheduled versus free reduction of steroid treatment in patients with active RA treated with adalimumab + MTX
Conditions
Interventions
- DRUG
-
adalimumab (up to 9 months exposure)
- DRUG
-
methotrexate
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Medical Information · Abbott
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-30
Countries
- United States
Study Locations
More Related Trials
-
Quality of Life Study With Adalimumab in Rheumatoid Arthritis
NCT00234936 ·Status: COMPLETED ·Phase: PHASE3
-
Methotrexate-Inadequate Response Study
NCT00559585 ·Status: COMPLETED ·Phase: PHASE3
-
Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis
NCT00234845 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
NCT00420927 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor
NCT01283971 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT04909801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate
NCT02393378 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study
NCT02433340 ·Status: COMPLETED ·Phase: PHASE2
-
Post-marketing Observational Study in Subjects With Rheumatoid Arthritis
NCT00234884 ·Status: COMPLETED
-
Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)
NCT00235885 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis
NCT00233571 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis
NCT01231321 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib
NCT03823378 ·Status: TERMINATED ·Phase: PHASE2
-
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
NCT01162421 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT02141997 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice
NCT01736189 ·Status: COMPLETED
-
Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
NCT02557100 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
NCT03823391 ·Status: COMPLETED ·Phase: PHASE2
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage
NCT01661140 ·Status: TERMINATED ·Phase: PHASE4
-
Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab
NCT01752855 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
NCT01764997 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
NCT00124982 ·Status: COMPLETED ·Phase: PHASE3
-
Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA
NCT01204138 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prospective Study on Intensive Early Rheumatoid Arthritis Treatment
NCT00480272 ·Status: COMPLETED ·Phase: PHASE4